+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Revision of MELD to include serum albumin improves prediction of mortality on the liver transplant waiting list



Revision of MELD to include serum albumin improves prediction of mortality on the liver transplant waiting list



Plos one 8(1): E51926



Allocation of donor livers for transplantation in most regions is based on the Model for End-Stage Liver Disease (MELD) or MELD-sodium (MELDNa). Our objective was to assess revisions to MELD and MELDNa that include serum albumin for predicting waiting list mortality. Adults registered for liver transplantation in the United States (2002-2007) were identified from the United Network for Organ Sharing (UNOS) database. Cox regression was used to determine the association between serum albumin and 3-month mortality, and to derive revised MELD and MELDNa scores incorporating albumin ('MELD-albumin' and '5-variable MELD [5vMELD]'). Among 40,393 patients, 9% died and 24% underwent transplantation within 3 months of listing. For serum albumin concentrations between 1.0 and 4.0 g/dL, a linear, inverse relationship was observed between albumin and 3-month mortality (adjusted hazard ratio per 1 g/dL reduction in albumin: 1.44; 95% CI 1.35-1.54). The c-statistics for 3-month mortality of MELD-albumin and MELD were 0.913 and 0.896, respectively (P<0.001); 5vMELD was superior to MELDNa (c-statistics 0.922 vs. 0.912, P<0.001). The potential benefit of 5vMELD was greatest in patients with low MELD (<15). Among low MELD patients who died, 27% would have gained ≥10 points with 5vMELD over MELD versus only 4-7% among low MELD survivors and high MELD (≥15) candidates (P<0.0005). Modification of MELD and MELDNa to include serum albumin is associated with improved prediction of waiting list mortality. If validated and shown to be associated with reduced mortality, adoption of 5vMELD as the basis for liver allograft allocation may improve outcomes on the liver transplant waiting list.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 055564679

Download citation: RISBibTeXText

PMID: 23349678

DOI: 10.1371/journal.pone.0051926


Related references

Higher Values in Liver Elastography and Meld Score Are Mortality Predictors on Liver Transplant Waiting List. Arquivos Brasileiros de Cirurgia Digestiva 31(1): E1360, 2018

Impact of MELD Allocation System on Waiting List and Early Post-Liver Transplant Mortality. Plos one 11(6): E0155822, 2016

Is the model of end-stage liver disease (MELD) valid in Israel? A critical analysis of liver transplant waiting list mortality. Israel Medical Association Journal 8(9): 605-609, 2006

Excess mortality on the liver transplant waiting list: unintended policy consequences and Model for End-Stage Liver Disease (MELD) inflation. Hepatology 61(1): 285-291, 2015

Liver transplant recipients mortality on the waiting list: long-term comparison to Child-Pugh classification and MELD. Transplantation Proceedings 36(4): 920-922, 2004

The MELD system and liver transplant waiting-list mortality in developing countries: lessons learned from São Paulo, Brazil. Einstein 10(3): 278-285, 2012

Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone. Liver Transplantation 11(3): 336-343, 2005

A model including sarcopenia surpasses the MELD score in predicting waiting list mortality in cirrhotic liver transplant candidates: A competing risk analysis in a national cohort. Journal of Hepatology 68(4): 707-714, 2018

Determinants of death on liver transplant waiting list Waiting time, blood group or MELD?. Hepatology 34(4 Pt 2): 204A, 2001

A nomogram with sarcopenia surpasses the MELD score in predicting waiting list mortality in cirrhotic liver transplant patients: a competing risk analysis in a national cohort. Journal of Hepatology 68: S377-S378, 2018

MELD scores with incorporation of serum sodium and death prediction in cirrhotic patients on the waiting list for liver transplantation: a single center experience in southern Brazil. Clinical Transplantation 26(4): E395, 2012

Validation of the five-variable Model for End-stage Liver Disease (5vMELD) for prediction of mortality on the liver transplant waiting list. Liver International 34(8): 1176-1183, 2014

MELD Impact of hepatocellular carcinoma on the adult liver transplant waiting list. Hepatology 38(4 Suppl 1): 374A, 2003

MELD scores do not predict patient morbidity while on the liver transplant waiting list. Transplantation Proceedings 37(5): 2174-2178, 2005

Prognostic Abilities and Quality Assessment of Models for the Prediction of 90-Day Mortality in Liver Transplant Waiting List Patients. Plos one 12(1): E0170499, 2017